Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
暂无分享,去创建一个
M. de Antonio | J. Lupón | A. Bayés‐Genís | J. Vila | E. Roig | J. González-Costello | C. Sánchez-Enrique | J. Comín-Colet | C. Enjuanes | E. Solé-González | P. Moliner | N. Farré | S. Ruiz | S. Mirabet | S. Pérez
[1] W. Khalife,et al. The prognosis of mid‐range ejection fraction heart failure: a systematic review and meta‐analysis , 2018, ESC heart failure.
[2] Roberto Ferrari,et al. Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.
[3] M. de Antonio,et al. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study , 2017, European journal of heart failure.
[4] M. Pfisterer,et al. Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) , 2017, European journal of heart failure.
[5] T. Shiroto,et al. Characterization of heart failure patients with mid‐range left ventricular ejection fraction—a report from the CHART‐2 Study , 2017, European journal of heart failure.
[6] R. Vazquez,et al. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure. , 2017, International journal of cardiology.
[7] M. Guazzi,et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction , 2017, European journal of heart failure.
[8] L. Lund,et al. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study , 2017, Circulation. Heart failure.
[9] F. Fernández‐Avilés,et al. Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure. , 2017, Revista espanola de cardiologia.
[10] A. Mebazaa,et al. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome , 2017, Clinical Research in Cardiology.
[11] M. Clèries,et al. Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients , 2017, PloS one.
[12] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[13] L. Allen,et al. Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction , 2016, Circulation. Heart failure.
[14] M. Clèries,et al. Medical resource use and expenditure in patients with chronic heart failure: a population‐based analysis of 88 195 patients , 2016, European journal of heart failure.
[15] J. Butler,et al. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. , 2016, JAMA cardiology.
[16] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[17] C. Yancy,et al. Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. , 2016, JACC. Heart failure.
[18] A. Shah,et al. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. , 2016, Circulation. Heart failure.
[19] M. Vaduganathan,et al. Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review , 2016, European journal of heart failure.
[20] J. Gore,et al. Magnitude of and Prognostic Factors Associated With 1‐Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings , 2015, Journal of the American Heart Association.
[21] K. Anstrom,et al. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial , 2017, European journal of heart failure.
[22] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.
[23] Deepak L. Bhatt,et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. , 2014, American heart journal.
[24] D. McManus,et al. Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. , 2014, The American journal of cardiology.
[25] B. French,et al. Heart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes , 2014, Circulation.
[26] Christina L. Clarke,et al. Natural History of Left Ventricular Ejection Fraction in Patients With Heart Failure , 2013, Circulation. Cardiovascular quality and outcomes.
[27] L. Allen,et al. Risk Factors for Adverse Outcomes by Left Ventricular Ejection Fraction in a Contemporary Heart Failure Population , 2013, Circulation. Heart failure.
[28] A. Hoes,et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. , 2013, Journal of the American College of Cardiology.
[29] Shannon M. Dunlay,et al. Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction , 2012, Circulation. Heart failure.
[30] Akshay S. Desai,et al. Heart failure with recovered ejection fraction: a distinct clinical entity. , 2011, Journal of cardiac failure.
[31] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.
[32] N. Lamblin,et al. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. , 2007, American heart journal.
[33] A. Nagai. [COPD (chronic obstructive pulmonary disease)]. , 2002, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[34] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .